Amanote Research
Register
Sign In
Cytological Reporting on Lung FNA and Small Biopsy Specimens in the Era of Personalized Medicine
Cancer cytopathology
- United States
doi 10.1002/cncy.21793
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 2, 2016
Authors
Mari Mino-Kenudson
Publisher
Wiley
Related search
Biobanking Metastases and Biopsy Specimens for Personalized Medicine
Journal of Biorepository Science for Applied Medicine
Observer Variability in Histopathological Reporting of Non-Small Cell Lung Carcinoma on Bronchial Biopsy Specimens
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
EGFR-gene Analysis on Cytological Specimens of Non-Small-Cell Lung Cancers
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
New Era of Personalized Medicine
Oncologist
Cancer Research
Medicine
Oncology
Detection of ROS1-positive Non-Small Cell Lung Cancer on Cytological Specimens Using Immunocytochemistry
Cancer cytopathology
Cancer Research
Oncology
The Importance of a Satisfactory Biopsy for the Diagnosis of Lung Cancer in the Era of Personalized Treatment
Current Oncology
Oncology
Cancer of Unknown Primary: Ancillary Testing of Cytologic and Small Biopsy Specimens in the Era of Targeted Therapy
Cancer cytopathology
Cancer Research
Oncology
Personalized Cancer Medicine: Era of Promise and Progress
Nature Reviews Clinical Oncology
Oncology
Metastatic Melanoma Moves On: Translational Science in the Era of Personalized Medicine
Cancer and Metastasis Reviews
Cancer Research
Oncology